CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

CUSP9 treatment protocol for recurrent glioblastoma was published one year ago. We now present a slight modification, designated CUSP9*. CUSP9* drugs- aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, sertraline, ritonavir, are all widely approved by regulatory autho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Richard E., Karpel-Massler, Georg, Halatsch, Marc-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226667/
https://www.ncbi.nlm.nih.gov/pubmed/25211298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226667/
https://www.ncbi.nlm.nih.gov/pubmed/25211298

Ejemplares similares